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During nervous system development, critical periods are usually defined as early periods during which manipulations dramatically
change neuronal structure or function, whereas the samemanipulations inmature animals have little or no effect on the same property.
Neurons in the ventral cochlear nucleus (CN) are dependent on excitatory afferent input for survival during a critical period of develop-
ment. Cochlear removal in young mammals and birds results in rapid death of target neurons in the CN. Cochlear removal in older
animals results in little ornoneurondeath.However, the extent towhichhair-cell-specific afferent activity prevents neuronal death in the
neonatal brain is unknown.We further explore this phenomenon using a newmousemodel that allows temporal control of cochlear hair
cell deletion.Hair cells express the humandiphtheria toxin (DT) receptor behind thePou4f3promoter. Injections ofDT resulted innearly
complete loss of organ of Corti hair cells within 1 week of injection regardless of the age of injection. Injection of DT did not influence
surrounding supporting cells directly in the sensory epitheliumor spiral ganglion neurons (SGNs). Loss of hair cells in neonates resulted
in rapid and profound neuronal loss in the ventral CN, but not when hair cells were eliminated at amoremature age. In addition, normal
survival of SGNs was dependent on hair cell integrity early in development and less so in mature animals. This defines a previously
undocumented critical period for SGN survival.
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Introduction
Normal development of sensory systems and sensory processing
is dependent on an organism’s interaction with its environment
and intact sensory receptor activity (Hebb, 1949; Grubb and
Thompson, 2004). Beginning with the classic contribution of
Levi-Montalcini (1949), studies have shown that sensory input
from the ear is necessary for the complete survival of developing
neurons in the cochlear nucleus (CN) of mammals and its avian
counterparts, the nucleusmagnocellularis and nucleus angularis.
That is, removal of the anlage of the inner ear early in develop-
ment or destruction of the cochlea early in postnatal develop-
ment causes massive cell death in the postsynaptic neurons in the
brainstem (Trune, 1982, 1983; Born and Rubel, 1985; Hashisaki
and Rubel, 1989; Tierney et al., 1997; Mostafapour et al., 2000;
Harris and Rubel, 2006). However, the equivalent manipulation
after this critical period results in little or no transneuronal neu-
ron loss and less pathology in the surviving neurons. Similar
phenomena are well documented in the visual system (Guillery,
1973; Kalil, 1980; Galli-Resta et al., 1993), olfactory system
(Frazier-Cierpial and Brunjes, 1989), and somatosensory sys-
tem (Baldi et al., 2000).
The cellular events underlying these interactions have been
studied extensively in brainstem auditory regions of birds and
mammals (Rubel and Fritzsch, 2002; Parks andRubel, 2004;Har-
ris and Rubel, 2006; Sanes andWoolley, 2011), particularly in the
spherical cell region of the ventral CN. These neurons are rather
uniform in size and shape, easy to count, and receive the over-
whelming majority of their excitatory input via the large, eighth-
nerve synaptic ending, the end bulb of Held (Ryugo and Parks,
2003; Lauer et al., 2013). This critical period corresponds to the
period before the development of behavioral and electrophysio-
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logical responses to sound. Destroying the cochlea in more ma-
ture mammals has little or no effect on neuronal survival. The
primarymethod used in the studiesmentioned above has been to
remove the entire sensory organ surgically, thereby damaging or
destroying all tissues in the inner ear, including the spiral gan-
glion neurons (SGNs). Therefore, it is impossible to determine
whether the source of trophic support in the young CN is hair
cells and the resulting changes in synaptic activity or other ele-
ments in the cochlea. Development of methods to prevent
transneuronal degenerative CNS changes after peripheral hear-
ing loss requires a model in which the hair cells are selectively
removed at any age.
Here, we characterize a mouse model that allows temporal
control of hair cell deletion by activation of the humandiphtheria
toxin (DT) receptor (hDTR) (Palmiter, 2001; Saito et al., 2001).
The hDTR is targeted to the Pou4f3 locus, which encodes a hair-
cell-specific transcription factor. A single systemic injection of
DT into neonatal or mature Pou4f3/DTRmice (heterozygous for
the DTR gene; referred to below as “DTR mice”) reliably causes
complete loss of cochlear hair cells. Using this model, we show
that, in contrast to adults, neuronal survival in the neonatal CN is
dependent on survival of the hair cells and we elucidate a new
critical period governing spiral ganglion cell survival.
Materials andMethods
DTR mice. Pou4f3 (Brn3.1, Brn3c) is a class IV POU domain transcrip-
tion factor that has a central function in the survival of all hair cells in
inner ear sensory epithelia (Erkman et al., 1996; Xiang et al., 1997).
Within the inner ear, only developing and mature hair cells express
Pou4f3; it is excluded from other cell types such as supporting cells and
SGNs (see Fig. 1A). Only one wild-type (WT) copy of Pou4f3 is needed
for normal development and hair cell function in mice (Erkman et al.,
1996).
The human heparin-binding epidermal growth factor-like growth fac-
tor (HB-EGF) acts as theDTR (Mitamura et al., 1995). Themouse equiv-
alent of this protein has several amino acid changes that make it resistant
to DT. Therefore, by expressing the human DTR gene in specific cells,
one can selectively ablate those cells without affecting other mouse cells
(Palmiter, 2001; Saito et al., 2001). To genetically engineer hDTR behind
Pou4f3, a BsiW1 site was inserted into the first Pou4f3 exon just upstream
of the initiation codon. A SpeI-SnaB1 fragment (5.9 kb) was cloned into
a targeting vector as the 5 arm upstream of a floxed SvNeo gene, and a
SnaB1-XbaI fragment (4.4 kb) was cloned downstream of the floxed
SvNeo gene as the 3 arm. The targeting construct also had flanking
Pgk-DTA and HSV-TK genes for negative selection. The full coding re-
gion for hDTR was cloned into the BsiWI site so that it represented the
first open reading frame. A floxed SVNeo gene was removed by breeding
with Mox2-Cre mice and the Mox2-Cre gene was removed from the
background by selective breeding. A representation of this construct is
shown in Figure 1B. Introduction of the human DTR gene behind the
Pou4f3 promoter sensitizes sensory hair cells to DT. Exogenous delivery
of DT should result in specific ablation of hair cells in the inner ear and,
depending on dosage, other cells expressing Pou4f3 in the body. Vestib-
ular hair cells are also ablated in this model (Golub et al., 2012).
Two different lines of DTR mice were generated using different back-
ground strains. Originally, C57BL/6J mice were used. A second line was
then created by backcrossing these mice into the CBA/J strain. All data
presented are derived from CBA/J mice unless otherwise indicated, but
similar results were obtained in all measures from both strains. Both
males and femaleswere used. Controls were age- and strain-matchedWT
littermates (Pou4f3/ mice) injected with DT and DTR mice injected
with physiological saline. DTR mice are phenotypically normal in terms
of hearing, balance, general health, and other obvious characteristics
until being injected with DT. To distinguish between DTRmice andWT
littermates, a tail biopsy was collected and DNA extracted using a DNA
blood and tissue kit (Qiagen). The target allele was amplified using PCR
(Dream Taq Green Master Mix; Fermentas) and the following primers
(0.4M): Pou4f3 (WT) forward 5CACTTGGAGCGCGGAGAGCTA
G; Pou4f3-DTR (mutant) reverse 5 CCG ACG GCA GCA GCT TCA
TGG TC. The PCRs were run using the following conditions: 95°C for 4
min, 25 cycles (95°C for 30 s, 59°C for 30 s, 72°C for 1 min) and 72°C for
7 min. PCR products were separated in a 1% agarose gel containing 0.25
g/ml ethidium bromide (expected band150 bp).
Mice were housed with open access to food and water and were
weaned from their mothers at 3 weeks of age. All procedures were ap-
proved by the Institutional Animal Care and Use Committee at the Uni-
versity of Washington (Seattle, WA) and adhered to the standards of the
American Veterinary Medical Association and the National Institutes of
Health.
Pou4f3 expression. Pou4f3 expression was verified in several ways: ex-
amining tissue from Pou4f3-GFP reporter mice, and by labeling tissue
with an antibody against Pou4f3. Tissue from Pou4f3-GFP reporter mice
at neonatal stages and at mature ages (Erkman et al., 1996; Masuda et al.,
2011) was kindly shared with us by Dr. Allen Ryan (University Califor-
nia–San Diego) to investigate GFP expression throughout the inner ear
and the brain. Expression in mouse brain was also studied with the Allen
Brain Atlas and examined by quantitative RT-PCR with RNA isolated
from freshly dissected tissue fromparts of the brain (forebrain,midbrain,
cerebellum, and hindbrain), as well as cochlea and liver in neonatal and
adult mice.
To examine Pou4f3 expression in the cochlea, temporal bones were
collected from mature WT littermates. Mice were terminally anesthe-
tized with isoflurane and transcardially perfused with 4% paraformalde-
hyde in PBS. Temporal bones were dissected. After opening the bulla, the
stapes was removed and a small opening was made in the apical turn of
the cochlea. The same fixative was gently perfused through the turns
of the cochlea via both the round and oval windows. Temporal bones were
then immersed in the same fixative for 2 h at room temperature. After
fixation, they were washed three times (10 min each) in PBS, pH 7.4, at
room temperature. If tissue was not dissected out of the temporal bone
the same day, it was kept at 4°C in PBS. The tissue was prepared as a
whole-mount preparation. The cochlear segments of the organ of Corti
were carefully dissected free from the bony labyrinth. The stria vascularis
was removed or trimmed and the tectorial membrane was removed with
a #55 forceps.Wholemounts of sensory epitheliumwere used to examine
Pou4f3 expression.
The mouse anti-Brn3c antibody (catalog #sc81980; Santa Cruz Bio-
technology, 1:200) was used to examine Pou4f3 expression. A rabbit
anti-myosin VI antibody (catalog #25-6791; Proteus Bioscience, 1:500)
was used to label the hair cells selectively. Tissue was permeabilized for
4 h with 0.1% saponin/0.1% Tween 20 in PBS. To prevent nonspecific
binding of the primary antibody, tissue was incubated for 1 h in a block-
ing solution consisting of 5% normal serum/0.1% Triton X-100 in PBS.
Primary antibody incubations were performed for 1 d at 4°C in PBS, 5%
donkey serum, and 0.1% Triton X-100. Fluorescent-labeled secondary
antibodies were used (Alexa Fluor-488, Alexa Fluor-568; Life Technolo-
gies) at a dilution of 1:400 in the same buffer for 2 h at room temperature.
Sections were washed after each incubation with antibody (three times
for 10–15 min each) in PBS. After counterstaining nuclei with DAPI
(catalog #D9542; Sigma-Aldrich, 1g/ml), the specimens weremounted
in Vectashield (Vector Laboratories), coverslipped, and examined with
confocal fluorescence microscopy.
Cultures of cochlea.Cochlear explants were prepared from both ears of
2- to 3-d-oldmouse pups (Pou4f3/DTRWT) and treated in vitrowith
or without DT for 3 d (25 ng/ml). The corresponding tail DNA of each
pup was isolated for PCR genotyping. Temporal bones were isolated and
placed in cold L15 medium. The bone overlaying the cochlea was care-
fully dissected away under a dissection microscope. The cartilaginous
capsule, stria vascularis, and Reissner’s membrane were then carefully
removed, leaving the organ of Corti attached to the spiral ganglion. A
total of 60 cultures (30 mice) from two litters were prepared. For each
ear, the apical, middle, and basal turns were cultured together, apical
surface up, on laminin-coated 8-well tissue culture slides (LabTek) in
OptiMEM (Life Technologies) supplemented with 5% fetal calf serum.
After 24 h in culture, 1/2 of the medium was removed and replaced for 1
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ear with media supplemented with DT at a final concentration of 25
ng/ml; for the opposite ear, the medium did not contain DT. Explants
were cultured for an additional 3 d before fixation with 4% paraformal-
dehyde for 2 h at 4°C. To get robust and complete hair cell labeling, two
antibodies were used to label the hair cells: a mouse monoclonal anti-
parvalbumin antibody (catalog #MAB 1572; Millipore, 1:1000) and a
rabbit anti-myosin VIIa (catalog #25-6790; Proteus Bioscience, 1:500).
To label supporting cells, a goat anti-Sox2 antibody (catalog #SC-17320;
SantaCruzBiotechnology, 1:500)was used. The tissuewas permeabilized
for 30 min with 0.1% saponin/0.1% Tween 20 in PBS, incubated for 1 h
in a blocking solution consisting of 5%normal serum/0.1%TritonX-100
in PBS, and in primary antibodies for 1 d at 4°C in PBS, 5% serum, and
0.1% Triton X-100. Fluorescent-labeled secondary antibodies were
used (Alexa Fluor-488, Alexa Fluor-568; Invitrogen) at a dilution of
1:400 in the same buffer for 2 h at room temperature. For mouse
antibodies against parvalbumin, the Mouse-on-Mouse kit (catalog
#BMK2202; Vector Laboratories) was used as specified by the manufac-
turer. Explants were washed after each antibody incubation (3 times for
10–15 min each) in 0.1% Tween 20 in PBS. After counterstaining nuclei
with DAPI (catalog #D9542; Sigma-Aldrich, 1 g/ml), the specimens
were mounted in Vectashield (Vector Laboratories), coverslipped, and
examined with confocal fluorescence microscopy.
PCR genotyping, as described above, was performed with tail DNA
corresponding to matched cochlear cultures. Post hoc analysis revealed
the expected 1:1 ratio of offspring from the cross (Pou4f3/DTRWT)
carrying the hDTR transgene and onlyPou4f3/DTR cultures treatedwith
DT showed extensive hair cell loss (15 of 60 cultures). WT cultures did
not show any DT-related toxicity (15 of 15).
Administration of DT. Mice received injection of DT as neonates or
when mature. All DT injections in both neonatal and mature mice
were made in the thigh muscle of the hind leg. Injection of DT at most
of the dosages used here (4–5 ng/g body weight in neonates and 25
ng/g body weight in mature mice) induced a phenotype of instability
and shakiness in the DTR mice that was detectable after only 2–4 d
and persisted for months. There was a 5% mortality rate after DT
injection at the doses described below.
Most of the neonatal mice in this study received injection of DT at
postnatal day 2 (P2). However, after discovering that hair cell loss occurs
well before the age of hearing onset in mice, subsequent neonatal exper-
iments were performed using P5 mice. This was done for the benefit of
increased survival andminimizing weight loss due to injection of DT. P2
mice received a single injection of DT at 4 ng/g body weight; P5 mice
received a single injection of 5 ng/g.
Mature mice varied in age from P21 to P42 at the time of injection
depending on the purpose of each specific experiment. For examining
variations in the amount, pattern, or timing of hair cell loss, ages varied
from 30 to 42 d at the time of injection and injection doses were 5, 15, or
25 ng/g. Studies of neuronal changes in CN used P21 mice to be consis-
tent with previous studies (Mostafapour et al., 2000; Harris and Rubel,
2006) and the DT dose was 25 ng/g. Mature DTRmice (defined asP21
for this study) given the 25 ng/g dose of DT were delayed in gaining
weight compared with their littermate siblings, but weight recovered to
normal levels by 14 d after DT treatment. WT littermates who also
received DT did not show reduced weight gain. Organ of Corti tissue
from both neonatally and mature-injected mice was examined at 2, 4,
6–8, 10, 14, 21, and 70 d postinjection (dpi). SGN and CN tissues were
examined at a subset of these survival times.
Cochlear hair cell counts. The time course of hair cell loss in neonates
was assessed at 2, 4, 6, 10, 14, and 21 dpi in both DTR and WTmice. All
animals in the group used for quantitative analyses were injectedwithDT
(4 ng/g body weight, i.m.) at P2. Cochleas were collected and dissected as
described above. Whole mounts of sensory epithelium were labeled with
antibodies against hair cells, supporting cells, and neurofilament with a
protocol similar to that used above for cultured cochleas. After the Sox2
labeling, neuronal axons and hair cells were labeled with a chicken anti-
neurofilament (catalog #AB-5539; Millipore, 1:5000), the mouse
monoclonal anti-parvalbumin antibody, and the rabbit anti-myosin
VIIa antibody described above with PBS washes in between. Primary anti-
body incubationswereperformed for1dat 4°C inPBS, 5%serum,and0.1%
Triton X-100. Fluorescent-labeled secondary antibodies were used (Al-
exa Fluor-488, Alexa Fluor-568, Alexa 647; Invitrogen) at a dilution of
1:400 in the same buffer for 2 h at room temperature. For mouse anti-
bodies against parvalbumin, the Mouse-on-Mouse kit (catalog
#BMK2202; Vector Laboratories) was used as specified by the manufac-
turer. Tissues werewashed, counterstainedwithDAPI, coverslipped, and
imaged as described below. Aminimumof three cochleas were processed
for each treatment protocol for every experimental group.
An IX-81 inverted microscope (Olympus) integrated into an FV-1000
laser scanning confocal microscope (Olympus) was used to view the
whole-mount preparations. Images were collected with a 10/0.40 nu-
merical aperture (NA) Olympus Universal Plan objective and a 40/1.3
NA Olympus Universal Plan oil-immersion objective. Sequential image
acquisition was performed to avoid bleedthrough using Fluoview soft-
ware, version 1.3a. Images were imported into ImageJ version 1.42a soft-
ware to createmaximum intensity projections from z-series stacks, which
were saved as 24-bit RGB TIFFs. The figures created with Adobe Photo-
shop CS version 8 were subjected to histogram stretch and adjustment to
fill the dynamic range and to compensate for printing. For quantification
of hair cell density, the number of hair cells was counted along a 200–350
mlength of sensory epithelium from each of five different regions along
the sensory epithelium. These five regions were evenly spaced across the
length of the sensory epithelium (apex tip to basal hook) and converted
to a linear density. Hair cells were counted in both WT and DTR mice.
The counts in the WT and DTR-injected littermates were averaged for
each region. A minimum of three cochleas were counted and averaged
for all data presented.
The procedures for quantification of hair cell loss after DT injection
were similar inmature animals (P25–P28) with the following exceptions.
Survival times after DT injections were 2–3 d, 4 d, and 6 d. Tissue was
processed for detection of hair cells (myosin VIIA and parvalbumin),
nerve processes (neurofilament), and cellular nuclei (DAPI). Samples
Table 1. Timeline of experiments and analysis
Pou4f3 expression
Tissue collected P2, P5, P22, and P75
Analysis Cochlea and brainstem tissue labeled for Pou4f3
Hair cell survival in vitro
Age harvested P2–P3
Time in culture before
treatment
24 h
Days of treatment before
fixing
3
Analysis Cultured cochlea labeled and imaged
Neonatal in vivo (cochlear, SGN, and CN changes)
Age at time of DT injection P2 (4 ng/g) or P5 (5 ng/g)
Tissue collected 2, 4, 6– 8, 10, 14, 21, and 70 dpi
Analysis Cochlea labeled and hair cells counted, Rosenthal’s
canal labeled and SGNs counted, cochlear
nucleus labeled and neurons counted
Mature in vivo (ABR testing)
Age at time of DT injection P28–P35 (25 ng/g)
Mice tested Immediately before and 1, 3, 5, 8, and 21 dpi
Tissue collected Immediately after ABR testing at each time point
Analysis ABR threshold identified, cochlea labeled, and hair
cells counted
Mature in vivo (dose response)
Age at time of DT injection P30–P42 (5, 15, or 25 ng/g)
Tissue collected 8 and 21 dpi
Analysis Cochlea labeled and hair cells counted
Mature in vivo (cochlear, SGN, and CN changes)
Age at time of DT injection P21–P42 (25 ng/g)
Tissue collected 2, 4, 6– 8, 10, 14, 21, and 70 dpi
Analysis Cochlea labeled and hair cells counted, Rosenthal’s
canal labeled and SGNs counted, cochlear
nucleus labeled and neurons counted
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were taken from three regions evenly spaced along the length of the
sensory epithelium (middle of apex, middle of middle, and middle of
basal turn) and converted to a linear density. In some cases, we collected
2 or 3 such lengths of epithelium in the same turn and averaged them to
get a single number for each region of each cochlea. The areas were
chosen strictly to be as close to the middle of the region with the caveat
that they were free of dissection artifacts. Hair cells were counted in both
WT littermates and DTR-injected mice. Data are presented as linear
densities for inner hair cells, outer hair cells, and total hair cells. A min-
imumof three cochleas were counted and averaged for all data presented.
The means and descriptive statistics were calculated for percentage
hair cells remaining. The data were loaded onto GraphPad Prism version
5.0a software. Analyses were performed using two-way ANOVA and Bon-
ferroni post hoc comparisons. Results were considered significant when
p 0.05.
Supporting cell counts. Supporting cell numbers were determined for
mature-injected animals at 2 time points, 8 and 70 d after DT, using a
nonbiased samplingmethod.Whole-mount preparations of apical turns
taken fromDT-injected ears (n 4/time point) and normal control ears
(WT injectedwithDT,DTR injectedwith saline,WT injectedwith saline,
n 2–4/paradigm/time point) were labeled to
detect organ of Corti support cells by labeling
for Sox2 and counterstained with DAPI. Sox2
labels the nuclei of all support cell subtypes and
does not label sulcus cell nuclei (Oesterle et al.,
2008). Tissuewas viewed at 60with anOlym-
pus FV-1000 confocal laser scanning micro-
scope. Each apical turn was typically
subdivided into 3 equal regions (regions A–C)
and each region was then subdivided into 4
smaller quadrants (quadrants 1–4). The quad-
rant to be imaged by confocal microscopy and
quantitatively analyzed was randomly selected
before beginning the data collection and was
maintained for all 3 regions (A–C) of the apical
turn. Each region imaged (area 0.045 mm2)
was recorded as vertical stack of confocal im-
ages (z-series at 1 m increments) through the
entire depth of the sensory epithelium. Density
estimates of the number of Sox2-positive sup-
port cell nuclei were determined for each sam-
pled region using the Cell Counter plug-in for
ImageJ by dividing the number of Sox2-
positive support cells by the length of the sen-
sory epithelium. Average numbers were
determined for each organ and mean values were computed for each
paradigm.Controls (WT injectedwithDT,DTR injectedwith saline,WT
injected with saline) were grouped together because there were no reli-
able differences in numbers of Sox2-labeled cells.
Auditory brainstem response. Auditory brainstem responses (ABRs)
were measured from several groups of mice. To assess the time course of
hearing loss, all mice were P28–P42 at the time of DT or saline injection
and 1/2 were male. All mice were tested before the DT injection to
establish premanipulation ABR thresholds. DTR mice receiving saline
injections and WT mice receiving DT were again retested at 8 dpi. DTR
mice were retested 1, 3, 5, 8 dpi. All groups had 3–5 mice. Mice were
anesthetized (ketamine, 100 mg/kg; xylazine, 5 mg/kg, i.p.), placed on a
heating pad to maintain body temperature near 37°C, and placed in a
sound-attenuating chamber. ABRs were recorded using standard subcu-
taneous needle electrodes with the positive and negative electrodes at the
left temporal bone above the pinna and the vertex of the skull and the
ground electrode in the thigh. Free-field pure tone stimuli were gener-
ated and ABR recordings were digitized using custom software. Tone
pips were 5 ms in duration with 1 ms rise/fall times presented at a repe-
Figure 1. Pou4f3 expression is limited to hair cells. Expression of Pou4f3was verified two ways: by labeling sectioned tissue with the Pou4f3 antibody and also using sectioned tissue from the
Pou4f3-GFP reporter mouse. A, Pou4f3 (green) is selectively expressed in the nuclei of hair cells (red) from amature (P56)WTmouse. An orthogonal view from the same section is shown in the top
inset. The Pou4f3-GFP reportermouse demonstrates expression in both inner and outer hair cells (lower inset). Scale bar, 100m.B, Pou4f3/DTRmicewere genetically engineered to contain the
DT receptor downstreamof thePou4f3promoter. Insertion of theDT receptor downstreamof thePou4f3promoter creates amousemodel inwhich sensory hair cells in the inner ear canbe selectively
ablated after a systemic injection of DT.
Figure 2. DT specifically eliminates hair cells in vitro in DTR mice. Cochlear explants were prepared from P2–P3 DTR and WT
mice and subjected to either no treatment or DT administration (25 ng/ml) for 3 d in culture and then immediately fixed and
subjected to immunolabeling. A, Untreated explants from DTR mice have intact inner hair cells (IHCs) and outer hair cells (OHCs)
(red). B, Treatment of explants from DTR mice with DT induces extensive loss of OHCs and complete loss of IHCs. There is no
apparent impact ofDTon supporting cells (green). Scale bar, 50m. Insets inAandB show low-power viewsof one representative
turn of corresponding explant cultures.
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tition rate of 19/s. In addition, broadband
clicks were presented at the beginning and end
of each session to assess for any changes in the
animal’s condition. All stimuli were calibrated
online at the beginning of each experiment
with a calibrated probe microphone placed at
the animal’s ear canal. Neural responses were
preamplified (100, P15 amplifier; Grass
Technologies), sent through anMA3 amplifier
with an additional 20 dB post-preamp gain
(Tucker Davis Technologies), band-pass fil-
tered (100–3000Hz; filtermodel 3550; Krohn-
Hite), and digitized at 24.4 kHz. Responses
were sampled in a 15 ms window (with a 5 ms
stimulus onset delay). The threshold was de-
fined as the lowest sound pressure level (SPL)
in which a recognizable waveform was present
and repeatable. Thresholds were determined at
4, 8, 16, and 32 kHz and for a broad-band click.
For WT animals, stimuli were presented 500
times from 80 to 20 dB SPL in steps of 10 and
then 1000 repetitions in steps of 5 dB SPLwhen
approaching threshold. Near threshold, each
series was repeated to determine the reliability
of the waveform at the estimated threshold and
5 dB above and 10 dB below the estimated
threshold. Stimuli for DTR mice were pre-
sented in the same way at 1000 repetitions.
When animals appeared to be deaf, all frequen-
cies were presented at intensities of 90, and 70
dB SPL for 1000 repetitions to be assured of a complete hearing loss.
SGN counts. Two different methods were used to assess SGN survival.
The first method used mice on the CBA/J background. One temporal
bone from each animal was used for hair cell counts and, in most cases,
the second temporal bone was decalcified, serially dehydrated in graded
alcohols, embedded in epoxy resin, and serially sectioned (1.5 m) ap-
proximately parallel to the midmodiolar plane. Consecutive sections
through the temporal bone were mounted on gelatin-coated slides,
stained with toluidine blue, and coverslipped. Sections approximately
every 50 m were used to image and count profiles of SGNs to sample
along the area representing high, middle, and low frequency. An Ax-
ioplan 2ie upright microscope (Zeiss) equipped with a CoolSnap HQ
camera (Photometrics) was used to view the sections. Images were col-
lected with a 20/0.3 NA Olympus apochromatic objective, 40/0.75
Figure 3. Hearing impairment inmature (P28) DTRmice after injection of DT. ABRs weremeasured inmaturemice at several times after injection of DT (25 ng/g). DTRmice have normal ABR
thresholds before DT injection (DTR control). Hearing loss is not apparent at 1 dpi in DTR mice. ABR thresholds are highly elevated by 3 dpi. By 5 dpi, mature mice did not respond to any stimulus
frequency (1),whereas these samemice have normal hearing thresholds before DT injection.WTmice have normal hearing 5 dpi (WT control). Data aremean	 SD,n 3–5per group. Statistical
analyses (two-way ANOVA followed by Bonferroni post hoc tests) yielded highly significant ( p 0.001) effect of groups and frequency aswell as the interaction term due to significant hearing loss
at 3 and 5 dpi in DTR mice. Difference between 1 d DTR animals and control groups is not significant ( p 0.10). Differences between 3 and 5 d DTR animals and all other groups are all highly
significant at all frequencies ( p 0.01). Difference between 3 and 5 dpi DTR animals is significant at 16 kHz ( p 0.05).
Figure 4. Cochlear hair cells are quickly lost in a dose-dependent manner after injection of DT in mature (P21) DTR mice. A,
Hair cells (green) remain largely intact inWT littermates after injection of 25 ng/gDT, even after long survival periods (shownhere,
21 dpi).B, Hair cells are swollen and unhealthy looking in DTRmice after 25 ng/g DT injection as early as 2 dpi (2d). C, By 6 dpi (6d),
essentially all inner and outer cochlear hair cells are gone. Terminal neurites labeled for neurofilaments (red) appear unaffected at
short time points. D, Hair cells of WT mice are not affected in any observable way by a smaller dose of DT (5 ng/g, shown here 21
dpi). E, At 5 ng/g, hair cells are lost over a slower time course. All inner hair cells are gone, but a few outer hair cells remain 8 dpi.
F, By 21 dpi with 5 ng/g,1% of hair cells remain and they are outer hair cells. All images here are from the basal turn of the
cochlea. Scale bar, 25m.
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NA Olympus apochromatic oil-immersion objective, or 100/1.40 NA
Olympus apochromatic oil-immersion objective. Images taken at the
20 magnification were used to delineate the contours of the apical,
middle, and basal turns of Rosenthal’s canal using ImageJ version 1.42a
software. Rosenthal’s canal was outlined by tracing along the bone sur-
face on the inside of the canal. Images taken at the 40 magnification
(tiled, when necessary) were used to count the number of type I and type
II neuronal profiles separately. Type I neurons were distinguished from
type II by the presence of myelin covering the cell body of the type I
SGNs. From these total counts, neuronal profile density was calculated:
the total number of neuronal profiles divided by the corresponding area
of Rosenthal’s canal. Density measurements were averaged across the
apical, middle, and basal regions for each animal.
The second method for assessing SGN survival used mice on a
C57BL/6J background. Isolated temporal bones were immersed in 0.1 M
EDTA to allow decalcification. Decalcified temporal bones were sub-
jected to frozen sectioning parallel tomid-modiolar plane. Serial floating
sections (30 m) were immunolabeled for neurofilament and tubulin
proteins using standard immunofluorescence methods. Briefly, tissue
was rinsed (PBS) and incubated at room temperature for 2 h in blocking
solution (5%normal horse serum in 0.2%TritonX-100 in PBS). Sections
were incubated overnight at room temperature with a combination of
primary antibodies: mouse anti-neurofilament (Developmental Studies
Hybridoma Bank, University of Iowa, 1:100) andmouse anti--III tubu-
lin antibodies (Covance, 1:500) to label neurons. Specimens were then
rinsed 5 in PBS and incubated for 2 h in secondary antibody conjugated
to Alexa Flour 546 (1:500). All of the specimens were coverslipped using
glycerol:PBS (9:1) as mounting media before microscopic imaging. Flu-
orescent imaging was performed using a Zeiss LSM 700 confocal micro-
scope. z-series images at an interval of 0.77 m were obtained using a
20 objectives. Image processing and quantitative analysis was per-
formed using Volocity 3D image analysis software (version 6.1.1;
PerkinElmer). To report spiral ganglion cell body counts, neurofilament-
and -III tubulin-labeled cell bodies in Rosenthal’s canal were counted
from the maximum intensity projections of the section. Cell bodies
counted from 4–5 sections (30 m each) per cochlea were averaged and
divided by the area of Rosenthal’s canal from which the neurons were
counted to get density measurements. Density measurements were aver-
aged across the apical, middle, and basal regions for each animal.
CN neuron counts. Mice were terminally anesthetized with isoflurane
and transcardially perfused with 4% paraformaldehyde. Brains were dis-
sected from the same mice used to assess hair cell survival (described
above) and from a group of long-term survival mice (70 dpi). Tissue
was postfixed in 4% paraformaldehyde at 4°C and stored in PBS at 4°C
for a minimum of 24 h, followed by croyprotection in 30% sucrose until
it sank. Coronal sections of the brainstems were cut with a sliding freez-
ing microtome at a thickness of 40 m. Every fourth section was
mounted onto gelatin-coated slides and allowed to dry. Slides were sub-
sequently hydrated, stained with thionin, differentiated, cleared in etha-
nol and xylene, and coverslipped with DPX mounting medium.
Neuronswere counted through the entire ventralCN(AVCNandPVCN,
6–10 sections per mouse, depending on age). The brains included in this
study were only those in which at least one side of the brainstem remained
intact through the entire ventral CN in every mounted section.
Bright-field images for stereological methods were acquired on a
Marianas imaging system controlled by Slidebook software, version
5.5 (Intelligent Imaging Innovations). This system included an Axio-
vert 200M inverted microscope (Zeiss) equipped with a motorized X, Y
stage (Advanced Scientific) and a CoolSnap HQ cooled monochrome
camera (Photometrics). The Slidebook stereology module was used for
systematic random sampling and optical fractionator counting boxes
(Gundersen et al., 1999). In brief, the entire VCN was outlined in a
low-magnification montage and counting frames (75  75 m) were
spaced every 200 m on the dorsal/ventral plane and 150 m on the
medial/lateral plane. A high-magnification z-stack was collected at each
sampling location using a 63/1.2 NA water-immersion objective and a
1 m z-step. Guard zones of 3 m were placed at each edge. The NeuN
antibodydoesnot label all neurons in theAVCN, so this labelwasnotused to
quantify neuronal loss. Inclusion of thionin-stained cells as neurons was
based on Nissl morphology, soma size, and presence of clearly defined nu-
cleoli, as described previously (Mostafapour et al., 2000, 2002). Population
estimates for the cochlear nuclei were calculated bymultiplying the recipro-
cal of volume fraction by the summedneuronal counts for all sections. Sam-
plingparameterswere chosen so that the coefficient of error for every case
was 10% using the Gunderson (m  1) Schmitz-Hof equation
(Gundersen et al., 1999; Schmitz and Hof, 2000).
The cross-sectional area of individual neurons in the AVCNwas mea-
sured from the stereology stacks by importing into Fiji 1.48p software.
The area was determined by outlining the stained portion of the soma in
the plane of maximum diameter. At least 50 neurons were measured per
mouse.
Statistics. Means were calculated for hearing threshold, percent hair
cell survival, neuron number, and neuron cross-sectional area. The data
were analyzed by t test or two-way ANOVA, where appropriate. Signifi-
cant main effects or interactions were followed up using Bonferroni post
hoc tests. Results were considered significant when p 0.05. Sample sizes
were chosen on the basis of previous studies. All analyses were performed
using GraphPad Prism version 5.0 for Mac OS X .
Figure 5. Quantification of hair cell density in each cochlear turn of mature (P21–P28) WT
mice and DTRmice at 2–3, 4, and 6 dpi (25 ng/g, i.m.). A, Total hair cells in each turn. B, Inner
hair cells. C, Outer hair cells. Ordinate scales are the same.Means SEM are shown. Datawere
analyzed by two-way ANOVA and Bonferroni post hoc tests for total hair cells, inner hair cells,
and outer hair cells separately. Major conclusions are that all hair cells are lost by 6 dpi, that
outer hair cells are lost before inner hair cells ( p 0.001), and that basal outer hair cells are lost
before apical outer hair cells ( p  0.01). WT mice injected with DT showed no significant
changes in hair cell density over this period in any region (data not shown).
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Results
To assist the reader’s understanding of the timeline of experi-
ments and treatments, a list and summary is provided in Table 1.
Pou4f3 expression
Pou4f3 expression is limited to hair cells in the sensory epithe-
lium. When the cochleas of either WT or DTR mice were incu-
bated with the Pou4f3 (Brn3c) antibody, selective labeling was
apparent exclusively in the nuclei of inner and outer hair cells
(Fig. 1A). On thebasis of labeling intensity, innerhair cells appear to
have greater expression of Pou4f3 than outer hair cells, but the nu-
cleus of every hair cell in the cochlea was labeled (Fig. 1A, top inset).
In neonatal mice (P2), some inner and outer hair cells in the apical
region of the cochlea appeared to lack Pou4f3 protein, but by P5, all
hair cells were labeled (data not shown). The selective expression in
hair cells was confirmed with the Pou4f3-GFP reporter mouse, in
which GFP could be seen throughout the entire hair cell instead of
being limited to the nucleus (Fig. 1A, bottom inset).
For the interpretation of results on SGN and CN neurons
reported below, it is also important to considerPou4f3 expression
throughout the brain, particularly the auditory brainstem, and in
the SGNs. We addressed this issue in several ways: (1) we exam-
ined the cochlea and brain in neonatal andmature mice from the
Pou4f3 reporter mouse (see also Masuda et al., 2011); (2) we
consulted the data on Pou4f3 mRNA expression in mature and
neonatal brain tissue in the Allen Brain Atlas (Lein et al., 2007;
http://www.brain-map.org); and (3) we used RT-PCR to assess
Pou4f3mRNAexpression in the cochlea and brainstem. Rigorous
evaluation of these data in developing and mature brains con-
firms that no Pou4f3mRNA is expressed in the SGN or CN of the
auditory brainstem, whereas Pou4f3 mRNA does seem to be ex-
pressed in other areas of the brain (e.g., striatum) and brainstem
(e.g., olivary nuclei), consistent with data in the Allen Brain Atlas.
Sections through the Pou4f3-GFP reporter mouse confirmed a
lack ofPou4f3 in theCN. Pou4f3mRNAexpression is also limited
to the cochleas compared with cochlear nuclei by quantitative
RT-PCR expression analyses (data not shown).
Hair cell survival in vitro
To demonstrate the selective sensitivity of hair cells to DT, co-
chlear explantswere prepared fromboth ears of P2–P3 pups from
Pou4f3/DTR  WT matings and cultured for 24 h in normal
medium (n 30 pups). After 24 h, the explant culture from one
ear was treated withDT (25 ng/ml) in themedium for 3 d and the
other ear (control explant) was not treated with DT. Exposure to
DT resulted in selective hair cell loss only in cultures from ani-
mals containing the Pou4f3DTR allele and only in the ear exposed
toDT. Immunolabeling (Fig. 2) shows extensive loss of outer hair
cells and complete loss of inner hair cells. The myosin VIIa stain-
ing that does remain is mostly associated with fragments of cells
rather than whole labeled cells with a DAPI-stained nucleus. We
observed no immediate qualitative changes in supporting cell num-
ber or morphology after 3 d of DT exposure in the cultures from
DTR pups. DT treatment had no effect on hair cells in WT co-
chlear cultures.
Figure 6. Cochlear hair cells are lost quickly after injection of DT in neonatal (P2) DTR mice. All data are fromWT and DTR mice injected with DT at P2 with 4 ng/g body wt. A, Hair cells (green)
remain largely intact inWTmice after injection of DT, even after long survival periods (shown here 14 dpi).B, Hair cells are swollen and unhealthy looking in DTRmice as early as 2 dpi. C,D, At 6 and
10 dpi, extensive loss of both inner and outer hair cells is apparent, with almost complete loss of inner hair cells and the remaining outer hair cells appearing pathologically swollen. E, F, At 14 and
21 dpi, all hair cells are gone in the basal turn, but a few hair cells (5%) remain in more apical regions (Table 2). Nerve fibers from SGNs (red) are also markedly reduced after substantial hair cell
loss, and this was especially apparent by 14 dpi and beyond. Scale bar, 25m.G, Graph displays loss of inner, outer, and total hair cells in themiddle of the basal turn of DTRmice. Data aremean	
SEM (n 3 cochleas from different mice). Statistical analyses (one-way ANOVA followed by Bonferroni post hoc tests) yielded significant effects of time dpi: *p 0.05 (2 vs 6, 10, 14, and 21 dpi);
 p 0.05 (2 dpi vs all others); ## p 0.05 (2 dpi vs all others); p 0.05 (4 vs 6, 10, 14, and 21 dpi); # p 0.05 (4 vs 6, 10, 14, and 21 dpi).
Table 2. Mean (SD) percent of cochlear hair cells remaining (normalized to age-
matched controls) in each region of the cochlea after neonatal DT injection
Days post-DT Apext tip Apex Mid Base Hook
Inner hair cells
2 65	 11 98	 9 103	 17 90	 10 95	 5
4 15	 5 52	 24 86	 6 48	 51 14	 16
6 40	 28 16	 15 23	 16 9	 16 7	 8
10 36	 19 13	 16 17	 14 8	 14 5	 8
14 30	 9 13	 7 1	 2 0 0
21 26	 7 21	 7 12	 7 2	 3 0
Outer hair cells
2 * * 75	 30 103	 12 101	 5
4 6	 6 5	 8 32	 19 56	 56 57	 21
6 * 29	 31 64	 19 27	 5 42	 56
10 0	 1 47	 21 71	 7 13	 11 9	 4
14 3	 5 0 0 0 0
21 7	 6 3	 3 0 0 0
Total hair cells
2 * * 79	 23 100	 12 100	 5
4 8	 6 14	 3 45	 16 54	 25 47	 16
6 * 27	 26 54	 8 23	 8 34	 41
10 10	 2 39	 13 59	 3 12	 6 8	 5
14 8	 2 36	 23 0	 1 0 0
21 12	 4 7	 1 3	 2 0	 1 0
*Loss of hair cell integrity and organization makes it difficult to count at this time point.
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Hearing impairment after injection of DT in vivo
ABR thresholds were determined for pure tones (4–32 kHz) in
DTR mice and their WT littermates. Mature (P30–P35) DT (25
ng/g)-injected mice were tested 1, 3, and 5 dpi (Fig. 3). Both WT
and DTR mice had normal ABR thresholds before DT injection
(DTR control) and at 1 dpi and were not statistically different
from each other at any frequency. Impairment progressed rap-
idly, however; by 3 dpi, reliable ABRs were only evoked at inten-
sities60 dB SPL and only at 16 kHz. By 5 dpi, none of the DTR
mice showed an ABR at 90 dB SPL (themaximum intensity avail-
able) for all frequencies presented. ABR thresholds at 3 and 5 dpi
were significantly impaired fromWT, DTR control, and 1 d sur-
vival thresholds (p 0.0001, two-way ANOVA, and p 0.0001,
Bonferroni post hoc test, no interaction between time after injec-
tion and frequency). Impairment persist-
ed; data from mice 8 and 21 dpi were
identical to data collected from mice 5
dpi and are therefore not shown in Fig-
ure 3. This functional deficit persists for
as long as we have studied the animals,
out to at least 3 months (see also Mahrt
et al., 2013). These mice do not respond
to any frequency or click at the highest
intensity level. Data shown in Figure 3
were collected from mice on a CBA/J
background, but a similar time course of
thresholds changes was observed in ma-
ture mice on a C57BL/6J background.
A smaller dosage of DT in DTR mice
(10 ng/g) delayed these functional deficits
by a day or two. Mature DTR mice in-
jected with only 5 ng/g DT failed to show
anABR to any frequency at 90 dB SPL by 8
dpi (data not shown).
Time course of cochlear hair cell loss
after injection of DT
To begin determining the optimal dose of
DT to ablate hair cells but maintain low
mortality and minimal effects elsewhere
in the body, several doses of DT ranging
from 5 to 25 ng/g body weight were ad-
ministered systemically to mature mice.
In WT mice injected with DT at 25 ng/g, most hair cells remain
healthy (Fig. 4A), but an occasional inner hair cell was lost at this
dose. InDTRmice injected at this dose, both inner and outer hair
cells died quickly after the injection of DT. Representative exam-
ples are shown in Figure 4, B and C, and numerical data are seen
in Figure 5. Hair cells were present 2 dpi (Fig. 4B), but their
morphology was obviously pathological. By 6 dpi, virtually all
hair cells were gone (Figs. 4C, 5). This did not happen uniformly
across the sensory epithelium. Loss was detected first mostly in
the basal turn, and proceeded toward the apex. This result can be
clearly seen in the outer hair cells (Fig. 5C; p  0.01), but is not
apparent in the inner hair cells (Fig. 5B). It is also readily apparent
from Figure 5 that inner hair cells are lost more slowly than outer
hair cells. At 6 dpi, we saw no viable appearing inner or outer hair
cells in our samples contributing toFigure 5. Inother animals, at day
6,wehave seenoneora fewnormal-appearinghair cells, especially in
the apical tip, but these account for3%of the normal compliment
of outer hair cells and do not appear in all animals. At 8 and 21 d, we
detectednoviable appearinghair cells in tissue reactedwithantibod-
ies against myosin VIIa and parvalbumin in most cases, although
occasionally a few (2%) outer hair cells remained.
A similar result occurred in DTR mice that received 15 ng/g
DT (data not shown). At 21 dpi, there were no detectable hair
cells at any location along the sensory epithelium (n  2 mice).
Less than 2% of hair cells remained at 8 dpi, and all hair cells
remaining at this time were outer hair cells.
Hair cell loss occurred somewhat more slowly in the mature
DTRmice that received 5 ng/g (Fig. 4E,F). In particular, at short
survival times,more outer hair cells remained. At 8 dpi, there was
a complete loss of inner hair cells (reflective of the strong Pou4f3
expression in the inner hair cells compared with outer hair
cells), but many of the outer hair cells were spared (Fig. 4E).
Less than 5% of outer hair cells were left in the basal half, and
50% were left in the apical half at 8 dpi. By 21 dpi, 1% of
Figure7. Effect of DT on supporting cells andperipheral neurites in the cochlea of DTRmice.A–C, Confocal images froma single
confocal stack taken from a DTR mouse injected with DT on P2 and allowed to survive 6 d (middle turn shown here). A, Merged
image with Sox2 labeling of organ of Corti supporting cell nuclei (red), neurofilament reactivity (white), and DAPI nuclear coun-
terstain (blue) and hair cells labeledwithmyosin VIIa (green). Note that, whereas hair cells are virtually completely gone, support-
ing cells appear unaffected at short survival times. B, Sox2 channel alone. C, Neurofilament channel alone. D, Neurofilament
labeling in the same region fromaDTRmouse injectedwithDTatP2, but allowed to survive90d; note extensive loss of neurites and
virtual absence of neurites crossing to the outer hair cell region. E–G, Confocal images from a single confocal stack taken from a
mature DTRmouse injected with DT on P40 and allowed to survive 7 d (apical turn shown here). E, Merged image labeled as in A.
F, Sox2 channel alone. G, Neurofilament channel alone.H, Neurofilament labeling in the same region from a DTRmouse injected
with DT at P40, but allowed to survive 75 d; note extensive labeling of neurites that is essentially as dense as seen after only 7 d
survival (G) and as seen inWTmice. Also note normal numbers of neurites crossing to the outer hair cell region. These tissueswere
also labeled with an antibody against myosin VII for hair cells. Four hair cells (green) are seen in A. All other hair cells have been
eliminated by the DT. Scale bar, 25m.
Figure8. Organof Corti supporting cell density remains stable afterDT injection inDTRmice.
Supporting cells (Sox2 cells) were quantified in the apical turn of experimental (DTR DT)
and control (WT injected with DT, DTR injected with saline, WT injected with saline) animals at
8 and 70 dpi using the nonbiased random sampling described in the Materials and Methods.
Each data value represents the mean	 SEM. Controls were grouped together because there
were no reliable differences in numbers of Sox2-labeled cells. Note the absence of significant
changes in support cell density after DT injection.
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hair cells remained (Fig. 4F ). The few
hair cells remaining were all outer hair
cells located in the middle turn and
basal hook regions.
As noted above, some hair cell loss oc-
curred inWTmice after 25 ng/g DT injec-
tion (Fig. 4A). This loss was only seen in
mature-injected mice and appeared to be
dependent on both the dose of DT and the
survival time. At 3 weeks after DT injec-
tion at this dosage in WT mice, hair cell
loss primarily was limited to inner hair
cells in the middle region of the sensory
epithelium; no outer hair cell losswas seen
in any region. This loss was reduced to
2% inmice that received 15 ng/g and no
hair cell loss was detected in mature WT
mice that received 5 ng/g (Fig. 4D).
Cochlear hair cell survival after
neonatal injection of DT
An important objective for our use of this
model was to delete cochlear hair cells be-
fore hearing onset (P12–P14; Rubel and
Fritzsch, 2002). This required systemic in-
jection of DT into early postnatal mice.
For the data reported in this section, mice
were injected at P2 (4 ng/g) to allow ample
time for hair cell loss before the onset of
hearing. In subsequent experiments, injec-
tions were made at P5 (5 ng/g). Waiting
these additional 3 d increased animal sur-
vival of neonates but still killed hair cells
completely before hearing onset in DTR
mice. Data from mice injected with DT
at P2 that survived for 2–21 dpi are shown
in Figure 6 and Table 2. Images of hair
cells are taken from themiddle of the basal
turn (Base) of the sensory epithelium (Fig.
6A–F); the graph shows group data from
the same region (Fig. 6G). Table 2 shows the percentage of inner
and outer hair cells remaining in each 200 m segment of the
cochlea [tip of the apex, middle of apical turn (Apex), middle of
middle turn (Mid), middle of the basal turn (Base), and hook] at
2–21 dpi. Inmice injected as neonates, cochlear hair cells began to
look swollen and unhealthy as early as 2 dpi (Fig. 6B). By 4 dpi,
1/2 of the hair cells were gone in the basal half of the cochlea. At
6 and 10 dpi, a fewhair cells were present, but themajority of both
inner and outer hair cells were gone (Fig. 6C,D). Loss of inner
hair cells was essentially complete by 14 dpi (Fig. 6E). As in the
mature-injected mice, loss of hair cells was detected first in the
basal hook and proceeded toward the apex (Table 2). Although
complete hair cell loss was apparent in the basal turn at 21 dpi
(Fig. 6F), the apical region of the cochlea did not completely lose
inner or outer hair cells, even at 21 dpi. As noted above, at P2,
some outer hair cells do not show antibody reactivity to Pou4f3.
We tentatively conclude that this is the reason for the persistence
of the outer hair cells in the apical region.
When DT injections were delayed until P5, hair cell loss pro-
ceeded more quickly and to a greater extent. By 8 d after P5
injection, hair cells were virtually all gone. There were 1% of
hair cells remaining and those few cells were outer hair cells,
again, typically located in the apical cochlea (data not shown).
No direct effect of DT on the supporting cells
Although expression of Pou4f3 is selective to hair cells in the
cochlea, we examined surrounding cell types to determine whether
their integrity was directly affected by DT administration (Figs. 7,
8). Of most importance for this question are analyses during the
time when the hair cells are dying. Analyses at later periods are
interesting as well but address a different issue, that of trophic
interactions between hair cells and supporting cells. Photomicro-
graphs taken during the first week after injection of DT in both
the neonatal (P2) and mature (P21) DTR mice showed healthy-
appearing supporting cells in both cases (Fig. 7B,F, respectively).
This is at a time when the majority of hair cells were gone due to
the injection ofDT, as shown by the few green cells (myosinVIIa)
remaining in Figure 7A and the fact that none remained in Figure
7E. To provide a quantitative assessment of supporting cell survival,
we counted the density of Sox2-positive cells in the organ ofCorti of
the apical turn inmature DTRmice injected with DT (25 ng/g) and
control animals at 8 and 70 dpi (Fig. 8). These data supported our
qualitative observations: the density of Sox2-positive cells in the or-
gan of Corti were essentially equivalent between DTR animals in-
jected with DT and control animals at 8 and 70 dpi (p 0.10).
We carefully (albeit qualitatively) assessed the integrity of the
nerve ending in the inner and outer hair cell regions using anti-
Figure 9. Age-dependent vulnerability of SGNs. Representative low-magnification (A–H ) and high-magnification (A–H)
photomicrographs are shown for short (8 d) and long (70 d) survivalWT and DTR animals injectedwith DT as neonates or when
mature (21 d). A, A, C, C, E, E, G, G, Low- and high-magnification images of SGN cell bodies remaining intact inWTmice after
DT injection regardless of age of injection or time after injection. B, B, SGN loss is detectable as early as 8 d after neonatal DT
injection in DTR mice. D, D, This loss continues in neonatal DTR mice and is extensive 70 dpi. F, F, Delaying injection until a
moremature age does not produce the same results. No loss is detectable after 8 d inmature DTRmice.H,H, Onlyminor SGN loss
can be detected long term in DTRmice, but not nearly to the extent seen in neonatally injectedmice. Examples of type I SGNswith
myelin wrapping of cell bodies and type II SGNs without myelin-surrounding cell bodies are shown in G by white arrows and
arrowheads, respectively. Scale bars: A–F, 50m; A–F, 10m.
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bodies to neurofilament protein and/or parvalbumin. In neona-
tally injected DTRmice at 6 dpi, the numbers of axons were quite
variable, with some animals showing a qualitatively normal pat-
tern and some showing a clear reduction in the region of the inner
hair cells (Fig. 7C). At longer survival times (e.g., 21 dpi) all
neonatally injected cochleas showed a marked loss of axons in
both the inner and outer hair cell regions (Fig. 7D). The survival
of axons in the organ of Corti of cochleas from mature mice
injected with DT was much more robust. Nerve fibers were still
present in qualitatively normal numbers and healthy looking in
all cases at both short (Fig. 7G) and long (Fig. 7H) survival times.
It will be of great interest to further study the survival of these
processes at a variety of survival times and determine the nature
of the trophic interactions.
Critical period for SGN survival
SGN density was examined at the level of the cell bodies in
Rosenthal’s canal and in the terminal dendrites in the cochlea.
Observations of the tissue (Fig. 9) andmeasurements of neuronal
density (Fig. 10) both suggest that SGN cell body survival de-
pends dramatically on the age when the DTR mice were injected
with DT. When neonatal DTR mice were injected with DT, they
showed profound loss of SGNs as early as 8 dpi (Fig. 9B). This loss
progressed such that only 30% of spiral ganglion cell bodies
remained at 70 dpi (Figs. 9D, 10A). WTmice injected with DT as
neonates did not have any observable SGN cell body loss at any
time point (Fig. 9A,C).
In stark contrast to the rapid and dramatic loss of SGNs in
neonatally injectedDTRmice, no detectable loss was seen at 8 dpi
inmice thatwere injectedwithDT as adults (Fig. 9F). By 70 dpi in
mature DTR mice, the cell bodies of the SGNs showed minimal
loss and appeared healthy (Fig. 9H) compared with age-matched
WT littermates in Figure 9, E and G, respectively. These qualita-
tive observations are supported by measures of SGN cell body
density and statistical comparisons shown in Figure 10A. Two-
way ANOVA on neonatally injected animals revealed a highly
significantmain effect of genotype (p 0.001) and no significant
interaction terms. Within the neonatally injected animals, there
was also a highly significant effect of genotype (p 0.01).
SGNs were also examined in DTR mice on a C57BL/6J back-
ground. Using different histological methods and the neurofila-
ment antibody to label SGN soma, similar results were observed
as reported above. SGN density depended on the age at which
DTRmice were injected with DT (Fig. 10B). Neonatal DTRmice
had a profound decrease in the density (44%) of spiral ganglion
cell bodies after 28 dpi at P7 (p 0.01). In contrast, there was no
detectable loss, even after twice that interval (56 d), in mice that
were injected with DT at a mature age.
These data suggest that, in addition to the critical period for
neuronal survival in the CN that has been reported by many
investigators in several species (Born and Rubel, 1985; Tierney et
al., 1997; Mostafapour et al., 2000; Rubel and Fritzsch, 2002), the
ability to selectively remove just the sensory hair cells reveals a
critical period for SGNs during which their integrity requires the
presence and/or activity derived from intact hair cells. Some cau-
tion should be exercised in the interpretation of these data. Al-
though it is clear from the tissue that there is a rapid and
profound loss of neurons in the neonatal DTR animals after DT
exposure, one must be more cautious about the apparent lack of
any change in the mature animals. Based on the small sample
sizes and the fact that density, not the total number, of neuronal
cell bodies was measured in our experiments, it is possible that
some neuronal loss does normally occur in mature animals, but
the number of cells that do die is relatively small and the time
course is protracted compared with the situation in neonates.
Nerve terminals from the SGNs labeled by the neurofilament
antibody can be seen in Figures 4, 6, and 7 We evaluated a large
number of cochleas from survival times ranging from 2 to 100 d.
Once the hair cells start to die in neonatally injected animals, the
nerve terminals in the cochlea became much sparser and had a
retracted morphology. By 70 dpi, the axons terminating in the
inner hair cell region were much less dense and the number of
axons crossing the organ of Corti was sparse ( 10% remained)
compared withWTmice. Qualitatively, some loss and retraction
of peripheral dendrites was apparent in mature mice injected
with DT, but this reaction was much less evident. In fact, the
surprising result is that even 70 d after complete hair cell loss, a
dense pattern of labeled processes was apparent in the region
previously occupied by inner hair cells; the number of radial
fibers appeared comparable to that seen in WT mice.
Critical period for neuronal death in the CN after injection
of DT
An important objective of this study was to determine whether
the age-dependent timing and magnitude of neuronal loss in the
CN of the brainstem depends entirely on the presence or loss of
hair cells. Previous studies detailing this critical period have all
used methods that damage the SGNs directly (e.g., surgical re-
Figure10. Critical period for SGNvulnerability to hair cell loss inDTRmice.A, SGNs are lost in
DTR mice on a CBA/J background if they are injected with DT as neonates (P2–P5). After 8 d,
partial loss (50%) is detectable and this progresses to66% loss by 70 dpi. In contrast,
10% loss is seen in mature (P21) DTR mice compared with WT littermates even at 70 dpi
despite a complete loss of hair cells. Both groups of neonatally injected DTR mice have signifi-
cantly reduced in SGN density ( p 0.001; two-way ANOVA followed by Bonferroni post hoc
test). DTRmice injected with DT at a more mature age have a significantly higher density of SG
neurons than DTR mice injected as neonates ( p 0.05; one-way ANOVA followed by Bonfer-
roni post hoc test). B, Densities of SG neurons from mice on a C57BL/6J background assessed
with neurofilament labeling. SGNs are lost in DTR mice only if they are injected with DT as
neonates. There is a reduction in SGN density 28 d after neonatal DT injection of DTR mice, but
not in age-matched WT mice nor in DTR mice in which DT injection was delayed until a more
mature age ( p 0.0001; two-way ANOVA followed by Tukey’s post hoc test).
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moval of the cochlea or ototoxic drug exposure) and other cell
types in the inner ear. The benefit of the DTR mouse model is
selective loss of hair cells without directly compromising SGNs,
supporting cells, or the stria vascularis.
As shown in Figure 11D, right, when 21-d-old DTRmice were
injected with DT (25 ng/g), there was no detectable CN neuron
loss at 21 dpi. There appeared to be a slight loss after 70 d, but
statistical analyses of the mature injected data from these
groups failed to reveal a significant two-way ANOVA. Perhaps
longer survival times or a larger number of animals would
reveal a small CN neuron loss, but such analyses remain to be
completed.
In neonatal mice injected with DT at P2, however, the results
are strikingly different. Figure 11C shows neuron counts in VCN
ofDTR andWTmice injected withDT and allowed to survive for
varying time intervals. A one-way ANOVA comparing all of the
WT groups did not approach statistical significance (p  0.26).
The data from these 12 animals were used to provide a more
accurate predictor of the normal cell numbers; the mean (	1
SEM) is shown as the open bars in Figure 11B. The shaded bars
show the mean and individual counts for 3–4 DTR animals at
each survival time. Neonatal CN neurons are very sensitive to
the selective loss of hair cells compared with age-matched WT
mice. Dramatic and significant neuron loss occurred as early
as 6 dpi (Fig. 11C) and persisted for as long as 70 dpi. Sig-
nificant differences between WT and DTR mice injected with
DT overall were seen (two-way ANOVA; p  0.0001) and
maintained at every time point (Bonferroni post hoc tests; all
p  0.01) and no significant interaction was seen. CN cell
counts in animals injected at P5 revealed essentially identical
results and comparisons of neonatal versus mature DTR mice
on a C57BL/6 background yielded the same overall results
(data not shown).
Neuronal size decreases after loss of hair cells
The cross-sectional area of VCN neuronal soma were measured
at selected times after injection in both neonatal andmatureDTR
and littermate WTmice exposed to DT. Previous studies suggest
that neuronal size decreases after both deafferentation and elim-
ination of presynaptic activity evenwhen no neuronal loss occurs
(Pasic and Rubel, 1989; Sie and Rubel, 1992). Here, we obtained
similar results (Fig. 12). In mice injected with DT as neonates, a
significant reduction in neuronal cross-sectional area was
seen, but not immediately. The small difference seen at 6 dpi
was not significant, but the reduction in VCN neuron size was
significant at 21 dpi (2-way ANOVA, interaction p  0.0024;
Bonferroni post hoc tests, p  0.01). The effect in mature DTR
micewasmore subtle, but therewas a highly significant reduction
in neuron size long term (p 0.001; Fig. 12C).
Figure11. Criticalperiodofneuronalvulnerability in theCNafterhair cell loss.A,Neurons in theventralCNofWTremain intactat70dafterneonatal (P2) injectionofDT.B,DTRmice injectedasneonates
are vulnerable toneuronal loss in the ventral CN. Scalebar, 50m.C, Neuron counts in VCN of DTRmice injectedwith DT at P2 and allowed to survive for varying time intervals comparedwith themean
andSEMof all DTR injectedWTmice. Aone-wayANOVAcomparingall theWTgroupsdidnot approach statistical significance ( p0.26). Thedata fromthese12animalswereused toprovide amore
accurate predictor of the normal cell numbers and that mean (	1 SEM) is shown as the open bars. The shaded bars show themean and individual counts for 3–4 DTR DT-injected animals at each
survival time. Neonatal CN neurons are very sensitive to the selective loss of hair cells compared with age-matchedWTmice. Dramatic and significant neuron loss occurred as early as 6 dpi (C) and
persisted for as long as 70 dpi. Significant differences between WT and DTR mice injected with DT overall were seen (two-way ANOVA; p 0.0001) and were maintained at every time point
(Bonferronipost hoc tests; allp0.01); no significant interactionwas seen.Neuronal lossbegins as early as6dpi inDTRmice injectedasneonates andpersists for at least 70dpi.D, Dramatic neuronal
loss is not evident in DTR mice injected as adults despite complete hair cell loss in the cochlea, even at 70 dpi. Data are mean	 SEM, n 2–5. Two-way ANOVA failed to show any significant
effects, although the small difference seen at the long survival time may warrant further study.
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Discussion
These studies provide three contributions. First, we describe and
characterize amodel system for investigating trophic interactions
between cellular elements in the inner ear and for investigating
the effects of hair cell viability on development and maintenance
of neuronal populations in the CNS. Second, we describe a new
critical period. In neonatal mice, input from intact hair cells,
presumably largely inner hair cells, is required to maintain the
full complement of SGNs. More than 50% of the SGNs rapidly
die when hair cells are eliminated in neonatalmice, whereas there
appears to be relatively little or no SGN death when hair cells are
eliminated in mature mice. Finally, we have used this mouse
model to test the hypothesis that hair cell integrity is required
for the trophic relationship between the ear and neurons of the
developing CN. Removing hair cells in neonatal mice results in
rapid and profound transneuronal degeneration in the ventral
CN, comparable to that seen with destruction of the entire co-
chlea, without causing direct damage to the supporting cells. The
same manipulation in mature mice does not result in neuronal
loss.
Pou4f3/DTR mouse model
Beneficial characteristics of the DTR mouse model are temporal
control over hair cell loss and speed, specificity, and completeness
of hair cell removal. The presence of the
hDTR sensitizes cells to DT without af-
fecting surrounding cell types (Palmiter,
2001; Saito et al., 2001). Direct effects of
systemic DT administration in the inner
ear appear limited to the hair cells in the
cochlea and vestibular epithelium of the
DTR mice (Golub et al., 2012). Adminis-
tration of DT in the first few postnatal
days ablates the hair cells before the onset
of hearing. Hair cell ablation can also be
delayed until maturity. We show virtually
complete (95%) hair cell loss and com-
plete loss of ABR by 6 d after DT injection
in mature mice and near complete loss of
hair cells in the first week when DT is ad-
ministered to neonates. In neonates and
maturemice, the hearing loss and hair cell
loss appears to be permanent (Mahrt et
al., 2013).
There are several other experimental
preparations for creating hair cell loss in
mice, all of which have been beneficial in
adding to our understanding of themech-
anisms and consequences of hair cell loss.
However, confounding factors limit in-
terpretations of experimental outcomes
related to studies of afferent regulation of
CNS neurons or hair cell regeneration.
When mature mice with a targeted dele-
tion of the high-affinity thiamine trans-
porter gene (Slc19a2) are maintained on a
low thiamine diet, they suffer robust loss
of inner and outer hair cells and impair-
ments in hearing (Liberman et al., 2006;
Zilberstein et al., 2012). Although this is a
useful model with which to study hair cell
loss in a mature animal, it takes several
weeks to induce maximum hair cell loss
and is therefore not appropriate for our studies on develop-
mental regulation and critical periods. A second genetic model
carries a hair-cell-specific (Atoh1-CreER) allele that allows
inducible expression of DT fragment A (Burns et al., 2012).
This model only allows ablation of hair cells in embryos or
animals early in the postnatal period because Atoh1 expression
turns off shortly after birth. Therefore, it is not useful for
comparisons between deafening in immature and mature an-
imals. Finally, many studies have used ototoxic compounds
(such as aminoglycosides) or high-intensity noise exposure.
Although hair cells show greater vulnerability to these treat-
ments than surrounding cells, both ototoxic drugs and noise
exposure are toxic to other components of the inner ear, in-
cluding ganglion cells, stria vascularis, and supporting cells,
when exposures are at a level that results in complete, or nearly
complete, loss of hair cells and profound hearing loss (Carlier
and Pujol, 1980; Wang et al., 2002; Hirose and Liberman,
2003; Oesterle et al., 2008; Oesterle and Campbell, 2009). Fur-
thermore, as highlighted by Murillo-Cuesta et al. (2010), it is
difficult to find two studies that used the same protocol of
aminoglycoside treatment in mice. Even local application of
ototoxic agents has the problem of enormous intersubject
variability (Heydt et al., 2004).
Figure 12. Neuronal cross-sectional area decreases slowly after cochlear hair cell loss. A, B, Photomicrographs of section
through the middle region of the ventral CN of mature WT and DTRmouse, respectively, 70 dpi. Note that a small difference in
neuron size is apparent,with soma area slightly smaller in DTRmouse CN. Scale bar, 25m. C, Cross-sectional areameasurements
of WT and DTR mice at various survival times. In neonatal mice injected with DT, neuronal size in the surviving neurons is
significantly decreased by 21 dpi. A small, but significant, decrease is also detectedwhenmaturemice are injectedwith DT, but on
amoredelayed time course; Data aremean	 SEM,n3–4; **p0.001 (vs age-matched controls); two-wayANOVAs followed
by Bonferroni post hoc tests.
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Critical period for SGN survival
SGN function and survival during development and after poten-
tially ototoxic insults has been of considerable interest due to
their importance related to medical and surgical treatments for
hearing loss. The large literature on neurotrophin- and activity-
mediated developmental events, including survival of SGNs, has
been reviewed recently (Leake et al., 2008; Green et al., 2012;
Leake et al., 2013; Moser et al., 2013; Seyyedi et al., 2013). Most
studies have used cats or rodents and produced cochlear insults
early in development to study SGNs after application of neurotro-
phins and/or electrical stimulation. In their “control groups,” in
which neonatal animals are treated with aminoglycosides or ami-
noglycosides in conjunction with diuretics to kill hair cells, SGN
loss is apparent shortly after hair cell loss (Leake et al., 1997). This
loss continues to increase formonths or years (Leake andHradek,
1988). Fewer studies have focused on SGN survival after hair cell
injury in adult animals. In one thorough series of studies, Kujawa
and colleagues (Kujawa and Liberman, 2009; Lin et al., 2011)
have followed changes in SGN axon density and SGN survival
after acoustic overstimulation. They observed rapid loss of syn-
apses and dramatic decreases in peripheral axon density within
days. However, loss of SGN cell bodies appears quite small and
occurred over a time course of months to years. These results are
consistentwith the results of Zilberstein et al. (2012) showing that
elimination of inner hair cells does not result in SGN death mea-
sured after 3 months.
The pattern of SGN loss seen in the Pou4f3/DTR mice pro-
vides convincing experimental evidence that there exists a critical
developmental period in mice where SGN survival is dependent
on intact hair cells. The precise age limits to the beginning and
end of this period are yet to be determined, but hair cell elimina-
tion before the onset of hearing results in rapid and profound
degeneration of SGNs,whereas even total elimination of hair cells
in mature animals results in relatively little or no SGN death.
These results, if replicated in other vertebrates, may have impor-
tant implications for habilitation and rehabilitation strategies
and provide a new useful system for investigating the molecular
mechanisms underlying critical periods in sensory system devel-
opment. The fact that this critical period is also a time of glial cell
maturation (Dinh et al., 2014) could be indicative of an underly-
ing mechanism of vulnerability.
Critical period for CN neuron survival
Aplethora of data support the conclusion that hearing loss result-
ing from elimination of the cochlea in birds or mammals causes
rapid and profound CN neuronal degeneration in young ani-
mals, but usually not in mature animals subjected to the same
surgical procedures (Rubel and Fritzsch, 2002; Harris and Rubel,
2006). In mice, this critical period ends by P14, about the time
when mice begin to hear external acoustic signals. From this lit-
erature, it is difficult to ascertain the origin of signals initiating
the transneuronal degeneration in young animals and whether
the developmental change in vulnerability rests with presynaptic
elements (e.g., SGN axons) or the postsynaptic cells in the CN. A
few studies have addressed these issues with activity blockers in-
troduced into the inner ear (Born and Rubel, 1988; Pasic and
Rubel, 1989; Sie and Rubel, 1992), but animal welfare concerns
prevent maintaining this manipulation for the more prolonged
period required for transneuronal degeneration. Results pre-
sented here indicate that the timing and magnitude of neuronal
loss and associated changes in the CN after hair cell elimination
using the DTR mouse are essentially identical to results after
removal of the cochlea and SGN inmice and gerbils (Trune, 1982;
Hashisaki and Rubel, 1989; Tierney et al., 1997; Mostafapour et
al., 2000; Harris and Rubel, 2006).
In contrast to most earlier studies in which subjects received a
unilateral cochlear removal, hair cell loss in the DTR mouse
model is bilateral and an internal control is lacking. This required
the use of stereology to make comparisons between animals.
Some neurons are small and indistinguishable from glial cells
using a Nissl stain. As a result, there may have been a slightly
lower estimate of neuron population in the mouse CN than re-
ported previously (Idrizbegovic et al., 2001). Regardless, a very
robust critical period was evident in the DTR mouse.
It is tempting to conclude from our data that the SGN neuron
loss is directly responsible for the critical period observed in the
CN; after hair cell elimination in neonates, SGNs and their target
neurons die, whereas both cell types live after hair cell elimination
in mature animals. This conclusion is proven false, however, by
the plethora of evidence that CN neurons do not die in mature
mammals after complete removal of the cochlea and SGN (Tier-
ney et al., 1997; Mostafapour et al., 2000). Conversely, it remains
to be determined whether CN neurons would be resistant to hair
cell loss in neonates if SGNs were preserved entirely.
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